A cation-pi interaction discriminates among sodium channels that are either sensitive or resistant to tetrodotoxin block.
Voltage-gated sodium channels control the upstroke of the action potential in excitable cells of nerve and muscle tissue, making them ideal targets for exogenous toxins that aim to squelch electrical excitability. One such toxin, tetrodotoxin (TTX), blocks sodium channels with nanomolar affinity only when an aromatic Phe or Tyr residue is present at a specific location in the external vestibule of the ion-conducting pore. To test whether TTX is attracted to Tyr401 of NaV1.4 through a cation-pi interaction, this aromatic residue was replaced with fluorinated derivatives of Phe using in vivo nonsense suppression. Consistent with a cation-pi interaction, increased fluorination of Phe401, which reduces the negative electrostatic potential on the aromatic face, caused a monotonic increase in the inhibitory constant for block. Trifluorination of the aromatic ring decreased TTX affinity by approximately 50-fold, a reduction similar to that caused by replacement with the comparably hydrophobic residue Leu. Furthermore, we show that an energetically equivalent cation-pi interaction underlies both use-dependent and tonic block by TTX. Our results are supported by high level ab initio quantum mechanical calculations applied to a model of TTX binding to benzene. Our analysis suggests that the aromatic side chain faces the permeation pathway where it orients TTX optimally and interacts with permeant ions. These results are the first of their kind to show the incorporation of unnatural amino acids into a voltage-gated sodium channel and demonstrate that a cation-pi interaction is responsible for the obligate nature of an aromatic at this position in TTX-sensitive sodium channels.
Santarelli
Vincent P
VP
Department of Molecular Physiology and Biophysics, Institute of Hyperexcitability, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA.
Eastwood
Amy L
AL
Dougherty
Dennis A
DA
Horn
Richard
R
Ahern
Christopher A
CA
D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D002412:Cations; D004305:Dose-Response Relationship, Drug; D004594:Electrophysiology; D005461:Fluorine / Q000737:chemistry; D008968:Molecular Conformation; D009124:Muscle Proteins / Q000737:chemistry*; D009865:Oocytes / Q000378:metabolism; D010649:Phenylalanine / Q000737:chemistry; D011485:Protein Binding; D051381:Rats; D015222:Sodium Channels / Q000737:chemistry*; D016808:Tetrahymena thermophila; D013779:Tetrodotoxin / Q000494:pharmacology*; D014443:Tyrosine / Q000737:chemistry; D014981:Xenopus
D000779:Anesthetics, Local; D002412:Cations; D009124:Muscle Proteins; C466180:Scn4a protein, rat; D015222:Sodium Channels; D005461:Fluorine; D014443:Tyrosine; D013779:Tetrodotoxin; D010649:Phenylalanine